Salarius Pharmaceuticals Inc. buy melinda
Start price
12.06.17
/
50%
€51,442
Target price
21.06.17
€57,784
Performance (%)
14.25%
End price
21.06.17
€58,771
Summary
This prediction ended on 21.06.17 with a price of €58,771. The BUY prediction by melinda finished with a performance of 14.25%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€49,892
15.04.17
15.04.17
€57,784
27.04.17
27.04.17
9.04%
27.04.17
27.04.17
